Laatste nieuws in biotech
Dutch Biotech Firm Secures €40 Million to Advance Nasal Sprays Protecting Against Respiratory Viruses
Leiden, Saturday 25 July 2026
Leyden Labs has secured €40 million, backed by Invest-NL and the Gates Foundation, to accelerate clinical trials for nasal sprays providing broad-spectrum protection against flu and coronaviruses.
Biotech Firm eXoZymes Secures US Funding to Create Virtual Models of Biological Manufacturing
Wageningen, Friday 24 July 2026
Partnering with a top US national laboratory, eXoZymes is utilising AI digital twins to simulate and optimise biological manufacturing, bypassing traditional, unpredictable living-cell variables.
Eli Lilly Agrees Multi-Billion Dollar Deal to Acquire Mental Health Specialist
Amsterdam, Saturday 18 July 2026
Pharmaceutical giant Eli Lilly is acquiring AtaiBeckley for up to $3.8 billion, gaining access to pioneering psychedelic-based therapies designed to treat severe, treatment-resistant depression.
